Status:
COMPLETED
Treatment of Gait Disorders in Children With Dravet Syndrome
Lead Sponsor:
Universiteit Antwerpen
Collaborating Sponsors:
University Hospital, Antwerp
KU Leuven
Conditions:
Dravet Syndrome
Severe Myoclonic Epilepsy of Infancy
Eligibility:
All Genders
3-25 years
Brief Summary
Dravet syndrome is a severe infantile onset epilepsy syndrome with a prevalence of 1/15.000 to 1/30.000. An infant with an apparently normal development presents around 6 months of age with a convulsi...
Detailed Description
The problem under investigation is the reduced functional mobility of patients with Dravet syndrome resulting from a crouch gait pattern. The solution, proposed in this research project, is the develo...
Eligibility Criteria
Inclusion
- diagnosed with Dravet syndrome according to the criteria of Ceulemans and Cras (2004)
- aged minimum 3 years and maximum 25 years at inclusion
- having minimum 1 year of walking experience
Exclusion
- severe epileptic seizure (status epilepticus or tonic-clonic insult over 3 min) within the 24 hours before the assessment
- insufficient cooperation to perform 3D gait analysis
- comorbidities of other neurological and/or orthopedic disorders not linked to Dravet syndrome
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03857451
Start Date
January 1 2017
End Date
December 31 2020
Last Update
April 14 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Antwerp
Antwerp, Belgium, 2160
2
University of Antwerp
Antwerp, Belgium, 2160
3
KU Leuven
Leuven, Belgium, 3000